Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil

Abstract Hepatitis C virus (HCV) infection is a worldwide health problem. Nowadays, direct-acting antiviral agents (DAAs) are the main treatment for HCV; however, the high level of virus variability leads to the development of resistance-associated variants (RAVs). Thus, assessing RAVs in infected p...

Descripció completa

Dades bibliogràfiques

Autors principals:	Elisabete Andrade, Daniele Rocha, Marcela Fontana-Maurell, Elaine Costa, Marisa Ribeiro, Daniela Tupy de Godoy, Antonio G.P. Ferreira, Amilcar Tanuri, Rodrigo Brindeiro, Patrícia Alvarez
Format:	Artigo
Idioma:	Inglês
Publicat:	Sociedade Brasileira de Genética 2020-02-01
Col·lecció:	Genetics and Molecular Biology
Matèries:	Direct-acting antivirals resistance-associated substitutions blood donors NS3 NS5b
Accés en línia:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000100107&tlng=en
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!